Prog Med Phys.  2020 Sep;31(S1):S60.

Dosimetric Evaluation of Acuros XB for Treatment Plan on Multiphasic Contrast Enhanced CT

Affiliations
  • 1Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Abstract

Purpose
Influence of treatment planning with multiphasic contrast enhanced computed tomography (CT) for liver cancer on dose calculation using Acuros XB (Varian Medical Systems, Palo Alto, CA), a grid-based technique to solve the linear Boltzmann transport equation was evaluated.
Methods
A homogeneous phantom with size of 20.0×20.0×20.0 cm3 was generated. To evaluate influence of presence of contrast agent on dose calculation, the phantom was filled with various Hounsfield unit (HU) of the phantom from 60 to 100 with steps of 10, corresponding to HU of liver for the non-contrast, arterial phase, portal phase, and delayed phase liver computed tomography (CT). Depth doses for a simple treatment plan various energies (6 MV, 10 MV, 6 MV FFF, and 10 MV FFF), a square field (10.0×10.0 cm2 ) and source-to-surface distance of 95 cm were calculated using Acuros XB (Ver. 15.6) and compared to those from anisotropic analytical algorithm (AAA).
Results
The depth doses were compared to those from the phantom filled with 60 HU, which was HU of normal liver on the non-contrast liver CT. Difference of the depth doses for lower energies were increased for higher HU. In dose calculation using AAA, differences of the depth doses were evaluated to be less than 1% for all the depth and energies. In dose calculation using AXB, differences of the depth doses for all the energies and HU were evaluated to be less than 1% up to the penetration depth of 12 cm, and the difference of the depth doses for the phantom filled with 70 HU were less than 1% only.
Conclusions
Although overall difference was evaluated to be acceptable clinically with less than 2%, dose calculation using AXB was influenced by the enhancing HU due to the presence of contrast agent, than dose calculation using AAA. However, as the material composition of the contrast agent could not be modified in the treatment plan using AXB, the treatment planning using the contrast enhanced liver CT should be evaluated carefully.

Keyword

AcurosXB; Contrast-enhanced CT; Treatment Plan
Full Text Links
  • PMP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr